Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
Oxidative stress related damage to sperm is believed to be a major cause of male infertility.
The object of the Menevit study is to investigate the role of a novel anti-oxidant
preparation (Menevit) on sperm function, embryo quality and pregnancy rates in an in vitro
fertilization (IVF) setting.